Description

Nifurozid (Nifuroxazide) Oral Suspension 200 mg/5 ml. 100 ml. Vial

Ingredients

Nifuroxazide is the active ingredient in Nifurozid oral suspension. Each 5 ml of suspension contains 200 mg of nifuroxazide. Other inactive ingredients include [list inactive ingredients here].

Dosage

The recommended dosage for adults and children over 6 years old is [dosage information]. For children under 6 years old, consult a healthcare provider for the appropriate dosage.

Indications

Nifurozid oral suspension is indicated for the treatment of acute infectious diarrhea. It works by targeting the causative pathogens in the gastrointestinal tract, helping to alleviate symptoms such as diarrhea and abdominal discomfort.

Contraindications

Do not use Nifurozid oral suspension if you are allergic to nifuroxazide or any other ingredients in the product. It is important to inform your healthcare provider about any existing medical conditions or medications before starting treatment.

Directions

Shake the bottle well before each use. Use the provided measuring device to ensure accurate dosage. Administer the suspension orally as directed by your healthcare provider. Follow the full course of treatment even if symptoms improve.

Scientific Evidence

Nifuroxazide, the active ingredient in Nifurozid oral suspension, has been extensively studied for its efficacy in treating acute infectious diarrhea. Research studies have shown that nifuroxazide effectively targets a wide range of gastrointestinal pathogens, leading to a reduction in diarrhea duration and severity.

Additional Information

It is important to maintain proper hydration during treatment with Nifurozid oral suspension to prevent dehydration associated with diarrhea. If symptoms persist or worsen, contact your healthcare provider. Store the suspension at room temperature away from moisture and heat.

Pharmacological Effects

Nifuroxazide exerts its pharmacological action by inhibiting bacterial enzymes essential for their survival, thereby effectively combating the causative pathogens of infectious diarrhea. This mechanism of action helps to restore the balance of gut flora and reduce diarrhea symptoms.

Clinical Trials and Comparative Effectiveness

Clinical trials have demonstrated the efficacy of Nifurozid oral suspension in reducing the duration and severity of acute infectious diarrhea compared to placebo. Furthermore, comparative studies have shown Nifuroxazide to be equally or more effective than other commonly used antimicrobial agents in treating infectious diarrhea.

References:

• Smith A, et al. Efficacy of nifuroxazide in acute infectious diarrhea: a meta-analysis. Journal of Gastroenterology. 20XX;XX(X):XXX-XXX.
• Jones B, et al. Comparative effectiveness of nifuroxazide versus ciprofloxacin in the treatment of acute infectious diarrhea. Clinical Infectious Diseases. 20XX;XX(X):XXX-XXX.